Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers
BMY
EXEL
ICPT
RHHBY
Tags
EXEL
Market News
ICPT
From
Motley Fool
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Tickers
AZN
AZNCF
RHHBY
TAK
Tags
Health Care
Biotech
AZN
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
General
RHHBY
Phase 3 Trial
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
ARVN
RHHBY
GOOG
From
Motley Fool
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Tickers
BNPQY
CYDY
EEENF
ETHE
Tags
Market News
SRUUF
Benzinga
From
Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
Tickers
GSK
MRK
RHHBY
SGEN
Tags
MRK
SGEN
Market News
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
SIOX
News
HILS
From
Benzinga
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
Benzinga
VRTX
PFE
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
BMY
Small Cap
Biotech
From
Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
Earnings
From
Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
NVS
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
Follicular Lymphoma
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
VIGL
CINC
Penny Stocks
From
Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
January 31, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Health Care
Market News
From
Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
January 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
Benzinga
From
Benzinga
These OTC Securities Had the Most Trading Activity in December
January 25, 2022
Tickers
ADDYY
AKZOY
BNPQY
CYDVF
Tags
DMGGF
CYDVF
FMCC
From
Benzinga
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
Tickers
ABBV
ARNA
BIIB
JPM
Tags
PFE
VRTX
Market News
From
Motley Fool
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
Tickers
AZN
BGNE
JPM
LPTX
Tags
JPM
Recent Press Releases
RHHBY
From
Motley Fool
Where Will Biogen Be in 5 Years?
January 15, 2022
Tickers
BIIB
NVS
RHHBY
SAGE
Tags
RHHBY
BIIB
Recent Press Releases
From
Motley Fool
Medicare pulls back on coverage of an Alzheimer’s drug
January 12, 2022
Tickers
BIIB
LLY
RHHBY
Tags
LLY
BIIB
RHHBY
From
MarketWatch
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
FDA
Benzinga
Trading Ideas
From
Benzinga
Why Shares of ImmunoGen Jumped 20.3% in December
January 03, 2022
Tickers
IMGN
RHHBY
Tags
Recent Press Releases
RHHBY
Market News
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Tickers
ALNY
ETON
IBB
NVS
Tags
Small Cap
Biotech
Previews
From
Benzinga
Why Lineage Cell Therapeutics Zoomed Higher Today
December 20, 2021
Tickers
LCTX
RHHBY
Tags
LCTX
RHHBY
Recent Press Releases
From
Motley Fool
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
December 20, 2021
Tickers
LCTX
RHHBF
RHHBY
RHHVF
Tags
Long Ideas
Market News
Penny Stocks
From
Benzinga
These OTC Securities Had the Most Trading Activity in November
December 16, 2021
Tickers
ADDYY
AYRWF
BNPQY
ETHE
Tags
LIACF
Small Cap
GBTC
From
Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
Tickers
ASRT
ATRS
BIIB
CALT
Tags
General
CGEM
IMMX
From
Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
December 16, 2021
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
why it's moving
Briefs
News
From
Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
December 15, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Phase 3 Trial
RHHBY
COVID/19 Coronavirus
From
Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
December 14, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
Diffuse Large B/Cell Lymphoma
From
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.